Prosecution Insights
Prosecution Insights
Tech Center 1600 • Art Units: 1671 1672
This examiner grants 26% of resolved cases
Marlene Vreni Buckmaster serves in Art Unit 1671 within Tech Center 1600. The examiner has a record of 31 resolved cases. The data indicates an allowance rate of 25.8 percent and a median days to allowance of 1359. These 31 resolutions establish the current performance metrics for the examiner. Applicants should anticipate a 1359-day timeline for successful applications in this unit. This information helps in planning the long-term strategy for patent filings in this technology area.
The interview lift is 78.1 percent. This 78.1 percent lift shows that applications with an interview are much more likely to be allowed than those without one. With a 25.8 percent allowance rate, the interview process is a critical factor for practitioners to consider. The 31 resolved cases provide a data set for evaluating outcomes in Art Unit 1671. The allowance rate and 1359-day median offer a detailed view of the prosecution environment in Tech Center 1600. Practitioners can use the 78.1 percent lift to inform their decision on whether to request a formal discussion.
| App # | Title | Status | Assignee |
|---|---|---|---|
| 17925920 | CORONAVIRUS ANTIGEN COMPOSITIONS AND THEIR USES | Final Rejection | Flagship Pioneering Innovations VI, LLC |
| 17713382 | METHODS FOR TREATING COVID-19 BASED ON INDIVIDUAL GENOMIC PROFILES | Non-Final OA | University of South Florida |
| 17905614 | VACCINES AGAINST SARS-COV-2 AND OTHER CORONAVIRUSES | Final Rejection | The Government of the United States, as Represented by the Secretary of the Army |
| 18015918 | A SIMPLE METHOD FOR COLLECTING A SAMPLE OF A MUCOSAL FLUID ADHERED TO THE MUCOSAL SURFACE OF THE NASAL CAVITY AND A TEST KIT FOR DETECTING AN ANALYTE IN THE SAMPLE | Final Rejection | Denka Company Limited |
| 17919096 | ADENOVIRUS IMMUNOASSAY METHOD AND IMMUNOASSAY INSTRUMENT | Non-Final OA | DENKA COMPANY LIMITED |
| 17906310 | PADLOCK PROBE-BASED ROLLING CIRCLE AMPLIFICATION PAIRED WITH NUCLEASE PROTECTION FOR POINT-OF-NEED NUCLEIC ACID DETECTION | Final Rejection | COLORADO STATE UNIVERSITY RESEARCH FOUNDATION |
IP Author analyzes examiner patterns and generates tailored response strategies with the highest chance of allowance.
Build Your Strategy